BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 32621798)

  • 1. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-mediated ALDH m
    Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
    Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 mediated m
    Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
    Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m
    Zhao W; Cui Y; Liu L; Ma X; Qi X; Wang Y; Liu Z; Ma S; Liu J; Wu J
    Mol Ther Nucleic Acids; 2020 Jun; 20():1-12. PubMed ID: 32145676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic m
    Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
    Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
    Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAMA3 Promotes Tumorigenesis of Oral Squamous Cell Carcinoma by METTL3-Mediated N6-Methyladenosine Modification.
    Ning B; Mei Y
    Crit Rev Immunol; 2024; 44(2):49-59. PubMed ID: 38305336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mettl3-mediated m
    Jiang FQ; Liu K; Chen JX; Cao Y; Chen WY; Zhao WL; Song GH; Liang CQ; Zhou YM; Huang HL; Huang RJ; Zhao H; Park KS; Ju Z; Cai D; Qi XF
    Elife; 2022 Nov; 11():. PubMed ID: 36399125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N
    Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W
    EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N
    Li F; Yi Y; Miao Y; Long W; Long T; Chen S; Cheng W; Zou C; Zheng Y; Wu X; Ding J; Zhu K; Chen D; Xu Q; Wang J; Liu Q; Zhi F; Ren J; Cao Q; Zhao W
    Cancer Res; 2019 Nov; 79(22):5785-5798. PubMed ID: 31530567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N
    Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
    Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.